Bicara Therapeutics Inc. Common Stock (BCAX NASDAQ) stock market data APIs
$29.0115
0.34(1.2%)
as of July 2, 2026
Try our APIs with
free plan!
Bicara Therapeutics Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Prev. Close
29.0115
Open
29.3548
High
29.8339
Low
28.9101
52 wk Range
8.74-29.9
Market Cap
1 905 M
Shares Outstanding
65 704 K
EPS
-0.93
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Bicara Therapeutics Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bicara Therapeutics Inc. Common Stock data using free add-ons & libraries
Get Bicara Therapeutics Inc. Common Stock Fundamental Data
Bicara Therapeutics Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -173 928 000
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Bicara Therapeutics Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-11
- EPS/Forecast: -0.65
Get Bicara Therapeutics Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bicara Therapeutics Inc. Common Stock News
New
What Does the Bicara Therapeutics CEO's Sale of 15,000 Shares Mean for Investors?
Key Points CEO Claire Mazumdar sold 15,000 shares for a transaction value of approximately ~$301,000, based on a weighted average price of around $20.04 per share on May 18, 2026. This represented 3....
What Does the Bicara Therapeutics CEO's Sale of 15,000 Shares Mean for Investors?
Claire Mazumdar, Chief Executive Officer of Bicara Therapeutics Inc. (NASDAQ:BCAX), reported the exercise of 15,000 stock options with immediate sale of the resulting common shares on May 18, 2026, as...
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet
Omega Fund Management disclosed a buy of 187,500 shares of Bicara Therapeutics(NASDAQ:BCAX) in a May 15, 2026, SEC filing, with the estimated transaction value at $3.23 million based on quarterly aver...
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back
On May 15, 2026, Omega Fund Management disclosed in an SEC filing that it sold 411,968 shares of Alumis(NASDAQ:ALMS), with the estimated transaction value at $10.3 million based on quarterly average p...
Get Bicara Therapeutics Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
